The article emphasizes the need for a shift towards patient-centric approaches in clinical research, especially within the rare disease space. By involving patients early in trial design and focusing on their experiences, sponsors can improve enrollment and retention, while also enhancing overall trial success. Engaging patient advocacy groups and adopting flexible processes are key steps to reinvigorating patient-centricity in research.
